| 1 |
Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
Daniel John O'Shannessy, Gordon H. Yu, Robert Smale et al. · Oncotarget
Open access |
29 Apr 2012 |
242 |
| 2 |
Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
Raffit Hassan, Steven J. Cohen, Martin D. Phillips et al. · Clinical Cancer Research
Open access |
29 Oct 2010 |
203 |
| 3 |
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.
Raffit Hassan, Wolfgang Ebel, Eric Routhier et al. · PubMed
Open access |
19 Dec 2007 |
189 |
| 4 |
Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma
Raffit Hassan, Hedy Lee Kindler, Thierry Marie Jahan et al. · Clinical Cancer Research
Open access |
18 Sep 2014 |
184 |
| 5 |
Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease
Daniel John O'Shannessy, Elizabeth Brooke Somers, Julia D. Maltzman et al. · SpringerPlus
Open access |
28 Sep 2012 |
158 |
| 6 |
Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration
Brian E. Tomkowicz, Katherine A. Rybinski, Brian Thomas Foley et al. · Proceedings of the National Academy of Sciences
Open access |
6 Nov 2007 |
158 |
| 7 |
Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
Deborah Kay Armstrong, Allen J. White, Susan C. Weil et al. · Gynecologic Oncology
|
6 Mar 2013 |
151 |
| 8 |
Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors
Brian M. Necela, Jennifer A. Crozier, Cathy A. Andorfer et al. · PLoS ONE
Open access |
27 Mar 2015 |
149 |
| 9 |
Investigation of the Impact of Substrate Selection on In Vitro Organic Anion Transporting Polypeptide 1B1 Inhibition Profiles for the Prediction of Drug-Drug Interactions
Saki Izumi, Yoshitane Nozaki, Kazuya Maeda et al. · Drug Metabolism and Disposition
|
21 Nov 2014 |
144 |
| 10 |
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.
Wolfgang Ebel, Eric Routhier, Brian Thomas Foley et al. · PubMed
Open access |
9 Mar 2007 |
138 |
| 11 |
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
Niklas K. Finnberg, Prashanth Ravishankar Gokare, Avital Lev et al. · Oncotarget
Open access |
5 Aug 2017 |
137 |
| 12 |
Expression of Folate Receptor-α (FRA) in Gynecologic Malignancies and its Relationship to the Tumor Type
Daniel John O'Shannessy, Elizabeth Brooke Somers, Robert Smale et al. · International Journal of Gynecological Pathology
|
22 Mar 2013 |
110 |
| 13 |
Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression
Akira Kurosaki, Kosei Hasegawa, Tomomi Kato et al. · International Journal of Cancer
Open access |
23 Nov 2015 |
107 |
| 14 |
Bioconjugation by Native Chemical Tagging of C–H Bonds
Qianghui Zhou, Jinghan Gui, Chung‐Mao Pan et al. · Journal of the American Chemical Society
Open access |
19 Aug 2013 |
107 |
| 15 |
MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity
Xin Cheng, Jing Li, Keigo Tanaka et al. · Molecular Cancer Therapeutics
|
27 Sep 2018 |
94 |
| 16 |
Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors
Mark Fairweather, Vinod P. Balachandran, George Z. Li et al. · Annals of Surgery
Open access |
27 Apr 2017 |
89 |
| 17 |
Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling
Brian E. Tomkowicz, Kathy Rybinski, Denise Sebeck et al. · Cancer Biology & Therapy
Open access |
Jun 2010 |
87 |
| 18 |
Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
Raffit Hassan, Charles Schweizer, Kun F. Lu et al. · Lung Cancer
Open access |
10 Sep 2009 |
86 |
| 19 |
Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed
Daniel Christian Christoph, Bernadette Reyna Asuncion, Biftu Hassan et al. · Journal of Thoracic Oncology
Open access |
14 Dec 2012 |
84 |
| 20 |
Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy
Evelyn Despierre, Sandrijne Lambrechts, Karin Leunen et al. · Gynecologic Oncology
|
2 Apr 2013 |
76 |
| 21 |
Characterization of the Human Folate Receptor Alpha Via Novel Antibody-Based Probes
Daniel John O'Shannessy, Elizabeth Brooke Somers, Earl F. Albone et al. · Oncotarget
Open access |
27 Dec 2011 |
73 |
| 22 |
Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers
Daniel John O'Shannessy, Elizabeth Brooke Somers, Li-chong Wang et al. · Journal of Ovarian Research
Open access |
13 May 2015 |
72 |
| 23 |
Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk
Xiaowei Chen, Joellen Weaver, Betsy A. Bove et al. · Human Molecular Genetics
Open access |
19 Jan 2008 |
71 |
| 24 |
A White Paper—Consensus and Recommendations of a Global Harmonization Team on Assessing the Impact of Immunogenicity on Pharmacokinetic Measurements
Jeffrey M. Sailstad, Lakshmi S. Amaravadi, Adrienne Clements‐Egan et al. · The AAPS Journal
Open access |
28 Mar 2014 |
67 |
| 25 |
A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors
Luis Alberto Diaz, Christina Marie Coughlin, Susan C. Weil et al. · Clinical Cancer Research
Open access |
15 Nov 2014 |
60 |
| 26 |
Gene Expression Analysis of Tumor Spheroids Reveals a Role for Suppressed DNA Mismatch Repair in Multicellular Resistance to Alkylating Agents
Giulio Francia, Shan Man, Beverly A. Teicher et al. · Molecular and Cellular Biology
Open access |
14 Jul 2004 |
59 |
| 27 |
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
Jianmin Lin, Jared L. Spidel, Christopher Maddage et al. · Cancer Biology & Therapy
Open access |
4 Oct 2013 |
54 |
| 28 |
Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4
Daniel John O'Shannessy, Elizabeth Brooke Somers, Leslie M. Palmer et al. · Journal of Ovarian Research
Open access |
17 Apr 2013 |
52 |
| 29 |
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature
Katherine A. Rybinski, Hongxia Z. Imtiyaz, Barrie Mittica et al. · Oncotarget
Open access |
4 Jul 2015 |
51 |
| 30 |
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology
Jian Li et al. · Proceedings of the National Academy of Sciences
Open access |
27 Feb 2006 |
50 |
| 31 |
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA–MORAb-003
Peter M Smith-Jones, Neeta Pandit‐Taskar, Wei Cao et al. · Nuclear Medicine and Biology
Open access |
19 Mar 2008 |
48 |
| 32 |
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) imaging
Liza Lindenberg, Anish Thomas, Stephen Adler et al. · Oncotarget
Open access |
4 Feb 2015 |
47 |
| 33 |
Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging
Marlène C.H. Hekman, Otto C. Boerman, Desirée L. Bos et al. · Molecular Pharmaceutics
Open access |
21 Aug 2017 |
44 |
| 34 |
Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream ® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha
Daniel John O'Shannessy, Darren W. Davis, Kenna Lynn Anderes et al. · Biomarker Insights
Open access |
2016 |
44 |
| 35 |
Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking
Xingfeng Bao et al. · Cancer Biology & Therapy
Open access |
2 Mar 2015 |
43 |
| 36 |
Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation
Paul Petrus, Tara L. Fernandez, Michelle Kwon et al. · EBioMedicine
Open access |
Jun 2019 |
41 |
| 37 |
Site-Specific Conjugation to Native and Engineered Lysines in Human Immunoglobulins by Microbial Transglutaminase
Jared L. Spidel, Benjamin Vaessen, Earl F. Albone et al. · Bioconjugate Chemistry
|
18 Aug 2017 |
41 |
| 38 |
Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins
Daniel John O'Shannessy, Elizabeth Brooke Somers, Lakshmi Krupa Chandrasekaran et al. · Oncotarget
Open access |
16 Jun 2014 |
39 |
| 39 |
Rapid high-throughput cloning and stable expression of antibodies in HEK293 cells
Jared L. Spidel, Benjamin Vaessen, Yin Yin Chan et al. · Journal of Immunological Methods
Open access |
25 Sep 2016 |
35 |
| 40 |
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
Kenneth H. Kim, Danijela Jelovac, Deborah Kay Armstrong et al. · Gynecologic Oncology
Open access |
28 Nov 2015 |
35 |
| 41 |
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms
Makoto Asano, Junji Matsui, Murray J. Towle et al. · Anticancer Research
|
30 May 2018 |
34 |
| 42 |
Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications
Eiji Kiyohara, Nicholas C. Donovan, Ling Takeshima et al. · Cancer Microenvironment
Open access |
17 Jun 2015 |
34 |
| 43 |
Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement
James Bradford Kline, Rina Kennedy, Earl F. Albone et al. · Oncotarget
Open access |
7 Jul 2017 |
33 |
| 44 |
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma
Sandra P. D’Angelo, Omid Hamid, Ahmad A. Tarhini et al. · Investigational New Drugs
Open access |
11 Nov 2017 |
32 |
| 45 |
Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
Nicholas C. Nicolaides, Daniel J. Oâ€TMShannessy, Earl F. Albone et al. · Frontiers in Oncology
Open access |
13 Jun 2014 |
32 |
| 46 |
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel F. Grothey, Jonathan Strosberg, Lindsay Anne Renfro et al. · Clinical Cancer Research
|
30 Oct 2017 |
31 |
| 47 |
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Brian Drozdowski, Yuhong Zhou, Brad Kline et al. · Journal of Immune Based Therapies and Vaccines
Open access |
Dec 2010 |
31 |
| 48 |
Development of124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
Ann‐Marie Chacko, Chunsheng Li, Madhura Nayak et al. · Journal of Nuclear Medicine
Open access |
13 Feb 2014 |
31 |
| 49 |
Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody
In‐Soo Shin, Sang-Myung Lee, Hyung Sub Kim et al. · Nuclear Medicine and Biology
Open access |
9 Jul 2011 |
31 |
| 50 |
Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe
Morgan Jouanneau, Brandon McClary, Jeremy Chris P. Reyes et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
24 Feb 2016 |
29 |